Nadolol in essential tremor
- 1 August 1983
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 33 (8) , 1076
- https://doi.org/10.1212/wnl.33.8.1076
Abstract
Nadolol, 120 and 240 mg daily, reduced essential tremor in a placebo-controlled double-blind study. The effect was observed in patients who had previously responded to propranolol but not in those who had not benefited from propranolol therapy.Keywords
This publication has 0 references indexed in Scilit: